Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma

Endocrine-Related Cancer

Volumn 11, Issue 2, 2004, Pages 345-356

  Botella Carretero, José I ^a   Gómez Bueno, Manuel ^a   Barrios, Vivencio ^a   Caballero, Carmen ^a   García Robles, Rafael ^a   Sancho, José ^a   Escobar Morreale, Héctor F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DIASTOLIC BLOOD PRESSURE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEART OUTPUT; HEART RATE; HUMAN; HYPOTHYROIDISM; MEAN ARTERIAL PRESSURE; SYSTOLIC BLOOD PRESSURE; THYROID CARCINOMA; THYROID HORMONE BLOOD LEVEL; WHOLE BODY SCINTISCANNING;

ADULT; BLOOD PRESSURE; CARCINOMA, PAPILLARY, FOLLICULAR; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; MYOCARDIUM; SUBSTANCE WITHDRAWAL SYNDROME; THYROID HORMONES; THYROID NEOPLASMS; THYROXINE; TRIIODOTHYRONINE;

EID: 3042598173     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0110345     Document Type: Article

References (61)

1. Arem R, Rokey R, Kiefe C, Escalante DA & Rodriguez A 1996 Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: effect of thyroid hormone therapy. Thyroid 6 397-402.
2. Asmah BJ, Wan-Nazaimoon WM, Norazmi K, Tan TT & Khalid BA 1997 Plasma renin and aldosterone in thyroid diseases. Hormone and Metabolic Research 29 580-583.
3. Banovac K, Papic M, Bilsker MS, Zakarija M & McKenzie JM 1989 Evidence of hyperthyroidism in apparently euthyroid patients treated with levothyroxine. Archives of Internal Medicine 149 809-812.
4. Basset A, Blanc J, Messas E, Hagège A & Elghozi JL 2001 Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study. Journal of Cardiovascular Pharmacology 37 163-172.
5. Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI & Schwaiger M 2000 Effect of thyroid hormones on cardiac function, geometry and oxidative metabolism assessed noninvasively by positron emisssion tomography and magnetic resonance imaging. Journal of Clinical Endocrinology and Metabolism 85 1822-1827.
6. Berry MJ, Banu L & Larsen PR 1991 Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349 438-440.
7. Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G, Sacca L, Bellastella A & Lombardi G 1993 Cardiac effects of long term thyrotropin suppressive therapy with levothyroxine. Journal of Clinical Endocrinology and Metabolism 77 334-338.
8. Biondi B, Fazio S, Palmieri EA, Tremalaterra R, Angellotti G, Bone F, Riccio G, Cittadini A, Lombardi G & Sacca L 1999 Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function. Cardiologia 44 443-449.
9. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G & Perticone F 2000 Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism 85 4701-4705.
10. Botella-Carretero JI, Galán JM, Caballero C, Sancho J & Escobar-Morreale HF 2003 Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma is impaired both by chronic therapy with suppressive doses of levothyroxine, and by levothyroxine withdrawal before whole body scanning with radioactive iodine. Endocrine-Related Cancer 10 601-611.
11. Carr AN & Kranias EG 2002 Thyroid hormone regulation of calcium cycling proteins. Thyroid 12 453-457.
12. Chan JS, Chan AH, Nie ZR, Sikstrom R, Lachance S, Hashimoto S & Carriere S 1992 Thyroid hormone, L-T3, stimulates the expression of the angiotensinogen gene in cultured opossum kidney (OK) cells. Journal of the American Society of Nephrology 2 1360-1367.
13. Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC & Gammage MD 1996 Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 75 363-368.
14. Danzi S & Klein I 2002 Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid 12 467-472.
15. Davis PJ & Davis FB 2002 Nongenomic actions of thyroid hormone on the heart. Thyroid 12 459-466.
16. DeGroot L, Manowitz N, Chait L & Mayor G 1997 Differential end organ responsiveness to suboptimal thyroid hormone concentrations as assessed by short-term withdrawal of levothyroxine sodium in athyreotic patients. 70th Annual Meeting of the American Thyroid Association, Colorado Springs, CO, USA.
17. Dickman MJ, Harms MP, Endert E, Wieling W & Wiersinga WM 2001 Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. European Journal of Endocrinology 144 339-346.
18. Dillmann WH 2002 Cellular action of thyroid hormone on the heart. Thyroid 12 447-452.
19. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F & Morreale de Escobar G 1995 Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. Journal of Clinical Investigation 96 2828-2838.
20. Everts ME, Verhoeven FA, Bezstarosti K, Moerings EP, Hennemann G, Visser TJ & Lamers JM 1996 Uptake of thyroid hormones in neonatal rat cardiac myocytes. Endocrinology 137 4235-4242.
21. Faber J, Petersen L, Winberg N, Schiffer S & Mehlsen J 2002 Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid 12 319-324.
22. Fazio S, Biondi B, Carella C, Sabatini D, Cittadini A, Panza N, Lombardi G & Sacca L 1995 Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade. Journal of Clinical Endocrinology and Metabolism 80 2222-2226.
23. Foley CM, McAllister RM & Hasser EM 2001 Thyroid status influences baroreflex function and autonomic contributions to arterial pressure and heart rate. American Journal of Physiology 280 H2061-H2068.
24. Fommei E & Iervassi G 2002 The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans, Journal of Clinical Endocrinology and Metabolism 87 1996-2000.
25. Grossman G, Wieshammer S, Keck FS, Göller V, Giesler M & Hombach V 1994 Doppler echocardiographic evaluation of left ventricular diastolic function in acute hypothyroidism. Clinical Endocrinology 40 227-233.
26. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD & Ridgway EC 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Journal of Clinical Endocrinology and Metabolism 84 3877-3885.
27. Hong-Brown LQ & Deschepper CF 1992 Effects of thyroid hormones on angiotensinogen gene expression in rat liver, brain, and cultured cells. Endocrinology 130 1231-1237.
28. Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, Ojima T & Shimada K 2003 Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. American Journal of Hypertension 16 434-438.
29. Hundahl SA, Fleming ID, Fremgen AM & Menck HR 1998 A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 83 2638-2648.
30. Ichihara A, Kobori H, Miyashita Y, Hayashi M & Saruta T 1998 Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. American Journal of Physiology 274 E224-E231.
31. Khattar RS, Swales JD, Banfield A, Dore C, Senior R & Lahiri A 1999 Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation 100 1071-1076.
32. Klein I & Ojamaa K 2001 Thyroid hormone and the cardiovascular system. New England Journal of Medicine 244 501-509.
33. Kobori H, Ichihara A, Suzuki H, Miyashita Y, Hayashi M & Saruta T 1997 Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. American Journal of Physiology 272 E227-E232.
34. Kobori H, Hayashi M & Saruta T 2001 Thyroid hormone stimulates renin gene expression through the thyroid hormone response element. Hypertension 37 99-104.
35. Levey GS & Klein I 1990 Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. American Journal of Medicine 88 642-646.
36. Marchant C, Brown L & Sernia C 1993 Renin-angiotensin system in thyroid dysfunction in rats. Journal of Cardiovascular Pharmacology 22 449-455.
37. Mazzaferri EL & Kloos RT 2001 Clinical review 128. Current approaches to primary therapy for papillary and follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism 86 1447-1463.
38. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW & Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 88 1433-1441.
39. Meier CA, Braverman LE, Ebner SA, Veronikis I, Daniels GH, Ross DS, Deraska DJ, Davies TF, Valentine M & DeGroot LJ 1994 Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). Journal of Clinical Endocrinology and Metabolism 78 188-196.
40. Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F & Mariotti S 2000 Cardiac function, physical exercise capacity and quality of life during long term thyrotropin suppressive therapy with levothyroxine: effect of individual dose tailoring. Journal of Clinical Endocrinology and Metabolism 85 159-164.
41. Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C & Ferrannini E 2001 Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 86 1110-1115.
42. Morkin E 1993 Regulation of myosin heavy chain genes in the heart. Circulation 87 1451-1460.
43. O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler WA, de Swiet M & Mee F 2000 Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. British Journal of Medicine 320 1128-1134.
44. Obuobie K, Smith J, Evans M, John R, Davies JS & Lazarus JH 2002 Increased central arterial stiffness in hypothyroidism. Journal of Clinical Endocrinology and Metabolism 87 4662-4666.
45. Ocon J & Ibeas J 2002 Nocturnal rhythm of arterial pressure. Nefrologia 22 Suppl 3 27-38.
46. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S & Imai Y 2002 Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. Journal of Hypertension 20 2183-2189.
47. Oppenheimer JH & Schwartz HL 1985 Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in the rat liver, kidney, brain and heart. Journal of Clinical Investigation 75 147-154.
48. Osman F, Gammage MD & Franklyn JA 2002 Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid 12 483-487.
49. Quesada A, Sainz J, Wangenstenn R, Rodriguez-Gómez I, Vargas F & Osuna A 2002 Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. European Journal of Endocrinology 147 117-122.
50. Robbins RJ & Robbins AK 2003 Clinical review 156. Recombinant human thyrotropin and thyroid cancer management. Journal of Clinical Endocrinology and Metabolism 88 1933-1938.
51. Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A & Drucker WD 2001 Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 86 619-625.
52. Ruiz M, Montiel M, Jimenez E & Morell M 1987 Effect of thyroid hormones on angiotensinogen production in the rat in vivo and in vitro. Journal of Endocrinology 115 311-315.
53. Sahún M, Villabona C, Rosel P, Navarro MA, Ramón JM, Gómez JM & Soler J 2001 Water metabolism disturbances at different stages of primary thyroid failure. Journal of Endocrinology 168 435-445.
54. Saito I & Saruta T 1994 Hypertension in thyroid disorders. Endocrinology and Metabolism Clinics of North America 23 379-386.
55. Sawin CT 2002 Subclinical hyperthyroidism and atrial fibrillation. Thyroid 12 501-503.
56. Schneider JJ & Hood DA 2000 Effect of thyroid hormone on mtHsp70 expression, mitochondrial import and processing in cardiac muscle. Journal of Endocrinology 165 9-17.
57. Sernia C, Clements JA & Funder JW 1989 Regulation of liver angiotensinogen mRNA by glucocorticoids and thyroxine. Molecular and Cellular Endocrinology 61 147-156.
58. Shapiro LE, Sievert R, Ong L, Ocampo EL, Chance RA, Lee M, Nanna M, Ferrick K & Surks MI 1997 Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. Journal of Clinical Endocrinology and Metabolism 82 2592-2595.
59. Skowsky WR & Kikuchi TA 1978 The role of vasopressin in the impaired water excretion of myxedema. American Journal of Medicine 64 613-621.
60. Umpierrez GE, Challapalli S & Patterson C 1995 Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism. American Journal of the Medical Sciences 310 99-102.
61. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F & Porcellati C 1990 Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81 528-536.